Hsu, T.-W.; Hsu, C.-N.; Wang, S.-W.; Huang, C.-C.; Li, L.-C.
Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients. J. Clin. Med. 2019, 8, 932.
https://doi.org/10.3390/jcm8070932
AMA Style
Hsu T-W, Hsu C-N, Wang S-W, Huang C-C, Li L-C.
Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients. Journal of Clinical Medicine. 2019; 8(7):932.
https://doi.org/10.3390/jcm8070932
Chicago/Turabian Style
Hsu, Tsuen-Wei, Chien-Ning Hsu, Shih-Wei Wang, Chiang-Chi Huang, and Lung-Chih Li.
2019. "Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients" Journal of Clinical Medicine 8, no. 7: 932.
https://doi.org/10.3390/jcm8070932
APA Style
Hsu, T.-W., Hsu, C.-N., Wang, S.-W., Huang, C.-C., & Li, L.-C.
(2019). Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients. Journal of Clinical Medicine, 8(7), 932.
https://doi.org/10.3390/jcm8070932